Close

Blueprint Medicines (BPMC) option implied volatility elevated into reporting data on its RET inhibitor BLU-667 at a cancer meeting

May 17, 2018 5:59 AM EDT

Blueprint Medicines (NASDAQ: BPMC) May call option implied volatility is at 127, June is at 77; compared to its 52-week range of 48 to 112 after reporting data on its RET inhibitor BLU-667 at a cancer meeting.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Options, Trader Talk

Related Entities

Options